Effects of Conjugated Equine Estrogen on Risk of Fractures and BMD in Postmenopausal Women With Hysterectomy: Results From the Women's Health Initiative Randomized Trial-Reference-Cited by-同舟云学术

Effects of Conjugated Equine Estrogen on Risk of Fractures and BMD in Postmenopausal Women With Hysterectomy: Results From the Women's Health Initiative Randomized Trial

Published:2006-05-08 Issue:6 Volume:21 Page:817-828
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J Bone Miner Res

Author:

Jackson Rebecca D,Wactawski-Wende Jean,LaCroix Andrea Z,Pettinger Mary,Yood Robert A,Watts Nelson B,Robbins John A,Lewis Cora E,Beresford Shirley AA,Ko Marcia G,Naughton Michelle J,Satterfield Suzanne,Bassford Tamsen

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Reference23 articles.

1. Epidemiology and outcomes of osteoporosis fractures;Cummings;Lancet,2002

2. www.healthypeople.gov/publications

3. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial;Writing Group for the Women's Health Initiative Investigators;JAMA,2002

4. Effects of estrogen plus progestin on risk of fracture and bone mineral density: The Women's Health Initiative randomized trial;Cauley;JAMA,2003

5. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: The Women's Health Initiative randomized controlled trial;Anderson;JAMA,2004

Cited by 203 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fractures by race and ethnicity in a diverse sample of postmenopausal women: a current evaluation among Hispanic and Asian origin groups;Journal of Bone and Mineral Research;2024-08-15

2. The relationship between treatment-related changes in total hip BMD measured after 12, 18, and 24 mo and fracture risk reduction in osteoporosis clinical trials: the FNIH-ASBMR-SABRE project;Journal of Bone and Mineral Research;2024-08-04

3. Hormone Replacement Therapy: Is It Always Necessary in Natural and Surgical Menopause?;Obstetrics and Gynecology;2024-05-04

4. Pre-treatment bone mineral density and the benefit of pharmacologic treatment on fracture risk and BMD change: analysis from the FNIH-ASBMR SABRE project;Journal of Bone and Mineral Research;2024-05-01

5. Bone health and the masters runner;PM&R;2024-03-27